◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › E › EDT

Spectral Medical Inc. (EDT) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-08-16

Spectral Medical Inc. (EDT) operates in the Diagnostics & Research industry and is headquartered in Toronto, Canada with about 29 employees. Its market capitalization is roughly CAD 405 million. In the fiscal year ended 2025-12-31, EDT reported CAD 2M in revenue and (CAD 48M) in net income.

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Interactive charts & full statements →

EDT Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CAD 2M	CAD 2M	CAD 2M	CAD 2M	—
Gross Profit	CAD 1M	CAD 1M	CAD 1M	CAD 1M	—
Operating Income (EBIT)	(CAD 12M)	(CAD 12M)	(CAD 8M)	(CAD 6M)	—
Net Income	(CAD 48M)	(CAD 15M)	(CAD 16M)	(CAD 11M)	—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EDT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	CAD 1M	CAD 1M	CAD 0M	CAD 1M	CAD 1M	—	—
Gross Profit	CAD 0M	CAD 1M	(CAD 1M)	CAD 1M	CAD 0M	—	—
Operating Income (EBIT)	(CAD 2M)	CAD 0M	(CAD 7M)	(CAD 2M)	(CAD 2M)	—	—
Net Income	CAD 0M	(CAD 3M)	(CAD 3M)	(CAD 30M)	(CAD 2M)	—	—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EDT Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	CAD 0M	CAD 0M	CAD 0M	—	—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EDT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	—	—	CAD 0M	CAD 0M	—	—	CAD 0M

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EDT Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CAD 6M	CAD 5M	CAD 5M	CAD 12M	—
Total Liabilities	CAD 76M	CAD 33M	CAD 22M	CAD 15M	—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EDT viewer.

Other Companies in Diagnostics & Research

OPK · OPKO Health, Inc. — $1 billion
CSTL · Castle Biosciences, Inc. — $979 million
LBIRD · Lumibird SA — $626 million
FLGT · Fulgent Genetics, Inc. — $527 million
IDHC · Integrated Diagnostics Holdings plc — $311 million
MYGN · Myriad Genetics, Inc. — $290 million
BDSX · Biodesix, Inc. — $253 million
0767 · Zhong Ji Longevity Science Group Limited — $248 million

← EDSA All “E” companies EDTK →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.